“In 2024, we plan to fortify our business in GCC & APAC regions”

Dr Harshit Jain is the Founder and Global CEO of Doceree, the first global network of
physician-only platforms for programmatic marketing. With Doceree, he is aiming to address the acute problem of rising cost of healthcare by bringing in efficiency and effectiveness in marketing to physicians by pharma brands on digital platforms with methodical use of data and creativity.

In this exclusive interaction, he shares his views on the company’s performance in 2023 and the outlook for 2024.

Looking back at 2023, what were the major milestones and achievements for Doceree? 

In 2023, Doceree achieved unprecedented success, marking a transformative year of growth, innovation, and industry recognition. As a leading enterprise technology in healthcare marketing, we proudly expanded our global reach, establishing partnerships with over 800 entities. Our cutting-edge solutions facilitated the implementation of 4000+ campaigns, generating a remarkable 1 billion+ impressions and engaging with 5 million+ Healthcare Professionals (HCPs).

Doceree’s remarkable performance is underscored by a 100% year-over-year growth, redefining the landscape of life sciences marketing globally. Securing over 35 million dollars in the latest Series B funding round within a mere 3.5 years since our inception reflects both our profitability and the industry’s confidence in our vision.

Our commitment to enhancing healthcare infrastructure through AI-powered solutions culminated in the launch of significant products. Doceree Enterprise, unveiled at Cannes 2023, offers a self-serve ecosystem empowering agencies to run highly targeted global and integrated campaigns with measurable outcomes. Additionally, we introduced two industry-first features – Assist for patient affordability and Insights, a ChatGPT-like AI assistant for marketers, streamlining campaign analysis.

Beyond business achievements, 2023 positioned Doceree as a thought leader in the global pharmaceutical industry. The launch of “The Next Marketing With HJ, Season 1,” a knowledge-exchange talk series, showcased my role as an interviewer engaging in insightful conversations on healthcare marketing with seasoned industry marketers.

In essence, 2023 has been a year of remarkable growth and influence for Doceree, as we continue to shape the future of healthcare marketing, innovate in AI-powered solutions, and foster meaningful dialogues within the industry.

How do you foresee the healthcare and pharmaceutical industry evolving in 2024, and what role does Doceree play in these changes? 

In the upcoming year of 2024, the surge in digital transformation within the healthcare sector will prompt leading pharmaceutical manufacturers to significantly increase their investments in digital marketing strategies, resulting in the generation of substantial volumes of patient data. This wealth of data is poised to serve as the foundation for data-driven decision-making, facilitating the development of targeted and highly effective marketing strategies and tactics.

Doceree, empowered by its proprietary HCP identity engine, Espyian™, will assume a pivotal role as a trusted intermediary between Healthcare Professionals (HCPs) and pharmaceutical marketers. As the world’s first Ad exchange for branded HCP messaging, Doceree will continue its mission to identify and precision-target over 4 million physicians globally. This precision targeting is designed for non-personal promotion and aims to deliver a personalized experience.

The integrated and collaborative ecosystem fostered by Doceree will create opportunities for pharmaceutical manufacturers and digital healthcare entities, including EHR platforms, health providers, healthcare systems, telehealth platforms, and electronic prescribing platforms. This collaborative approach is intended to unlock untapped potential in the realm of physician marketing through data science. Crucially, these endeavours will be executed with strict adherence to regulatory compliance, transparency, and efficiency, ultimately contributing to the development of efficient and affordable healthcare solutions.

Emerging trends in healthcare that you believe will have a significant impact in 2024?

Fueled by technological advancements and shifts in consumer behavior, the landscape of life sciences marketing is undergoing a rigorous transformation. In light of these changes, I anticipate that 2024 will witness similar yet significant trends and marketing initiatives within the life sciences sector, with technology playing a pivotal role in shaping its trajectory.

Pharmaceutical manufacturers are increasingly inclined to harness mainstream channels, prompting substantial investments in digital platforms. This strategic shift extends to virtual events, webinars, and online communities dedicated to product launches, knowledge-sharing, and networking. The objective is to reach healthcare professionals (HCPs) more efficiently, aligning with the evolving preferences and practices of this critical audience.

Moreover, the reliance on AI-powered solutions is poised to become a cornerstone for pharmaceutical manufacturers. These solutions will play a key role in interpreting intricate data sets, optimizing marketing campaigns, and ultimately enhancing the return on investment (ROI). The integration of AI extends to real-time targeting strategies, tailoring content and messaging based on individual preferences. This personalized approach aims to elevate script lift outcomes and overall campaign effectiveness.

Recognizing the paramount importance of compliance with regulatory standards and data security, pharmaceutical manufacturers will prioritize these aspects. This commitment ensures the ethical and secure handling of sensitive information, aligning with industry standards and building trust among stakeholders.

Any specific regions or markets where Doceree aims to make a substantial impact in 2024?

We will concentrate in The United States, UK, and India and fortify our business in GCC and APAC regions. We are also receiving interest from Japan and Australia, and we will investigate ways in which we can serve customers in these markets.

Strategic partnerships that Doceree is planning to pursue in the new year to strengthen its position in the market?

Doceree is actively pursuing a strategy of acquiring other companies in the tech and innovation sector to enhance its market position, innovation capabilities, and global presence. This proactive approach ensures that the company remains at the forefront of technological advancements and continues to deliver cutting-edge solutions for healthcare.

How do your personal aspirations align with the vision and mission of Doceree for 2024?

A leader’s core values serve as the bedrock for the prosperity of any company, and I’ve dedicated myself to instilling the fundamental values of integrity, inventiveness, and collaboration into the operations of Doceree. Witnessing the recognition garnered over the past year for our efforts in building a more effective healthcare system has been immensely rewarding. These exciting times have brought forth significant milestones for me as well as Doceree, from securing a remarkable $35 million investment in our Series B capital round to me earning a position on the board of POCMA.

My overarching goal with Doceree remains centred on fostering relationships that not only entice more opportunities but also leave a lasting impression. Looking ahead to 2024, my aspiration is to propel both my personal and professional journey forward by securing increased investment for Doceree. This vision extends beyond mere financial backing; it encompasses a strategic expansion of geographies and a thoughtful diversification and enhancement of our product portfolio. The objective is to fortify the foundations of Doceree, ensuring not only its continued success but also its positive impact on the markets it serves. This commitment reflects not just a personal ambition but a collective dedication to advancing healthcare innovation and positively influencing the industry we passionately serve.